The 4 Pulmonology Conditions Every FNP Student Must Master Before Board Day
Pulmonology · 4 min read · November 5, 2026
Introduction
Pulmonology is a heavy hitter on both the AANP and ANCC family nurse practitioner certification exams. When you sit down for your board exam, you can guarantee you will face complex respiratory cases that test your ability to differentiate between similar presentations, interpret diagnostic tests, and select the correct first-line pharmacological treatments. Let us break down the four most critical pulmonology topics you need to know to walk into your exam with total confidence.
1. Asthma Versus COPD: Differentiating Obstructive Lung Diseases
Both asthma and chronic obstructive pulmonary disease (COPD) feature reversible or irreversible airflow obstruction, but their underlying pathology and management strategies differ significantly. Asthma is characterized by chronic airway inflammation and hyper-responsiveness, whereas COPD involves progressive, partially reversible airflow limitation linked to an abnormal inflammatory response to noxious particles or gases (most commonly cigarette smoke).
When reviewing spirometry for boards, remember that an FEV1/FVC ratio of less than 0.70 post-bronchodilator confirms the diagnosis of COPD. For asthma, the diagnosis is supported by history and physical exam, and confirmed by spirometry showing reversibility (an increase in FEV1 or FVC of 12% and 200 mL after albuterol administration).
Clinical Pearl: Always look for the 'reversibility' clue in the vignette. If a patient's lung function normalizes or significantly improves after a bronchodilator, think asthma. If the obstruction persists despite treatment, think COPD.
2. Community-Acquired Pneumonia (CAP): Outpatient Treatment Selection
Community-acquired pneumonia is a board favorite, especially regarding appropriate antibiotic stewardship in outpatient settings. Before prescribing, you must determine whether the patient has any comorbidities or recent antibiotic use within the past three months, as this dictates your drug choice.
For a healthy adult with no comorbidities and no recent antibiotic use, first-line outpatient treatment is amoxicillin (1g TID), doxycycline, or a macrolide (azithromycin) only if local pneumococcal resistance is less than 25%. If the patient has comorbidities (such as heart, lung, liver, or renal disease, diabetes, or alcoholism) or recent antibiotic use, use combination therapy: a beta-lactam (such as augmentin or cefpodoxime) plus a macrolide or doxycycline, or monotherapy with a respiratory fluoroquinolone (such as levofloxacin).
Board Tip: Watch out for the 'recent macrolide use' distractor on exam questions. If a patient took azithromycin six weeks ago for sinusitis and now presents with CAP, prescribing a macrolide again is incorrect due to resistance risks; choose a respiratory fluoroquinolone or combination therapy instead.
3. Recognizing and Staging COPD Exacerbations
Managing stable COPD is one thing, but board exams love to test acute exacerbations. A COPD exacerbation is defined by an acute worsening of respiratory symptoms that goes beyond normal day-to-day variations and leads to a change in medication. The three cardinal symptoms are increased breathlessness, increased sputum volume, and increased sputum purulence.
Management of an acute exacerbation includes short-acting bronchodilators, systemic corticosteroids (e.g., prednisone 40 mg daily for 5 days), and antibiotics if the patient has increased sputum purulence plus at least one other cardinal symptom, or requires mechanical ventilation.
Clinical Pearl: Do not forget to evaluate whether your COPD patient needs long-term oxygen therapy. Criteria include an arterial oxygen tension (PaO2) of 55 mm Hg or less, or an oxygen saturation (SaO2) of 88% or less, confirmed twice over a three-week period.
4. Pulmonary Embolism: Spotting the Red Flags
A pulmonary embolism (PE) is a medical emergency that can easily mimic other cardiopulmonary conditions like asthma or pneumonia. Classic presentation includes acute onset dyspnea, pleuritic chest pain, tachypnea, and tachycardia. Risk factors include immobility, recent surgery, malignancy, hypercoagulable states, and estrogen therapy.
When faced with a suspected PE on boards, look at how the question frames risk stratification. Use the Wells Criteria to estimate clinical probability. If a patient has a low-to-intermediate probability, a D-dimer blood test is a great initial screening tool. However, if the patient is high risk, skip the D-dimer entirely and proceed directly to a CT pulmonary angiography (CTPA), which is the gold standard diagnostic imaging.
You have put in the hard work during your FNP program, and you have what it takes to pass these board exams. Take a deep breath, trust your clinical instincts, and let us help you cross the finish line.
Ready to elevate your board prep? Head over to The FNP Review to access high-yield Qbanks and expert resources designed specifically for FNP students.